Dissemin is shutting down on January 1st, 2025

Published in

European Centre for Disease Prevention and Control, Eurosurveillance, 16(26), 2021

DOI: 10.2807/1560-7917.es.2021.26.16.2100348

Links

Tools

Export citation

Search in Google Scholar

Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021

Journal article published in 2021 by Tjede Funk, Anastasia Pharris, Gianfranco Spiteri, A. Garcia-Leon, Nick Bundle, L. O’Connor, Angeliki Melidou, N. Murphy, Michael Carr, Gabriel Gonzalez, Niamh Murphy, Fiona Crispie, Alessandra Lo Presti, Z. Yandle, Joël Mossong and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0–2.9; B.1.351: 3.6, 95% CI: 2.1–6.2; P.1: 2.6, 95% CI: 1.4–4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4–3.5; P.1: 2.2, 95% CI: 1.7–2.8).